Scilex Holding Co
For the period ended Dec 31, 2024. Filed Mar 31, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 31, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Power of Attorney (included on the signature page hereto)
SIGNAT URES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| March 31, 2025 | Scilex Holding Company | |
|---|---|---|
| By: | /s/ Jaisim Shah | |
| Jaisim ShahChief Executive Officer and President (Principal Executive Officer) | ||
| March 31, 2025 | |
|---|---|
| By: | /s/ Stephen Ma |
| Stephen MaChief Financial Officer(Principal Financial Officer) | |
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints, jointly and severally, each of Jaisim Shah and Stephen Ma, acting alone or together with another attorney-in-fact, as his attorney-in-fact, with full power of substitution and resubstitution, for him in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact, or his substitute, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.
| Name | Title | Date |
|---|---|---|
| /s/ Jaisim Shah | Chief Executive Officer, President and Director | March 31, 2025 |
| Jaisim Shah | (Principal Executive Officer) | |
| /s/ Stephen Ma | Chief Financial Officer | March 31, 2025 |
| Stephen Ma | (Principal Financial and Accounting Officer) | |
| /s/ Henry Ji, Ph.D. | Executive Chairperson and Director | March 31, 2025 |
| Henry Ji, Ph.D. | ||
| /s/ Dorman Followwill | Director | March 31, 2025 |
| Dorman Followwill | ||
| /s/ Jay Chun | Director | March 31, 2025 |
| Jay Chun, M.D., Ph.D. | ||
| /s/ Yue Alexander Wu | Director | March 31, 2025 |
| Yue Alexander Wu, Ph.D. | ||
| /s/ Annu Navani | Director | March 31, 2025 |
| Annu Navani, M.D. | ||
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
| Report of Independent Registered Public Accounting Firm (PCAOB ID: 207) | F-2 |
|---|---|
| Consolidated Balance Sheets as of December 31, 2024 and 2023 | F-3 |
| Consolidated Statements of Operations and Comprehensive Loss for the Years ended December 31, 2024 and 2023 | F-4 |
| Consolidated Statements of Stockholders’ Equity / (Deficit) for the Years ended December 31, 2024 and 2023 | F-5 |
| Consolidated Statements of Cash Flows for the Years ended December 31, 2024 and 2023 | F-7 |
| Notes to Consolidated Financial Statements | F-9 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.